Andheri Pharmaceuticals Pvt Ltd
About Andheri Pharmaceuticals Pvt Ltd
Data last updated:
Andheri Pharmaceuticals Pvt Ltd is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 December 1993 and has been in existence for over 33 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1993PTC075565.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹10,000. It is led by directors Hufriz Basta and Pharaoh Percy Basta.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Andheri Hon Pharmacy313 Vivina Apartments Andheri West, Mumbai, Maharashtra, India – 400058.
As per the financials filed for FY 2020, the company reported a revenue of ₹9.72 Lakh, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹29,089 (net margin 3%) and EBITDA of ₹41,339 (EBITDA margin 4.3%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 10% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Andheri Pharmaceuticals Pvt Ltd's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressAndheri Hon Pharmacy313 Vivina Apartments Andheri West, Mumbai, Maharashtra, India – 400058
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Andheri Pharmaceuticals Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Andheri Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Andheri Pharmaceuticals Pvt Ltd, buy the company report.
Financials of Andheri Pharmaceuticals Pvt Ltd
FY 2020 filings availableAndheri Pharmaceuticals Pvt Ltd reported revenue of ₹9.72 Lakh (up 1% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 1% growth in the latest year. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹41,339 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹29,089 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.3% | ||||
| Net Profit Margin | 3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Andheri Pharmaceuticals Pvt Ltd, buy the company report.
Board of directors of Andheri Pharmaceuticals Pvt Ltd
Andheri Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hufriz Basta Also directs: Homeo House (India) P Ltd, Ghatkopar Homeopathic Pharmacy P Ltd, Fort Homeo Pharmacy Private Limited and 1 more | Director | 13 Dec 1993 | 32 Years 10 Months | Current |
| Pharaoh Percy Basta Also directs: Homeo House (India) P Ltd, Ghatkopar Homeopathic Pharmacy P Ltd, Fort Homeo Pharmacy Private Limited and 1 more | Director | 13 Dec 1993 | 32 Years 10 Months | Current |
Auditor
Andheri Pharmaceuticals Pvt Ltd is audited by H F K MADAN & CO for the financial year 2015.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| H F K MADAN & CO | FY 2015 | 113950W |
Shareholding
The shareholding of Andheri Pharmaceuticals Pvt Ltd is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Andheri Pharmaceuticals Pvt Ltd, buy the company report.
Legal cases
No court or tribunal cases involving Andheri Pharmaceuticals Pvt Ltd are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Andheri Pharmaceuticals Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Andheri Pharmaceuticals Pvt Ltd; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Andheri Pharmaceuticals Pvt Ltd has 2 board changes on record since 1993: 2 appointments. The latest: Hufriz Basta was appointed as Director on 13 Dec 1993.
Frequently asked questions
Andheri Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 December 1993 (33+ years old) and is registered under CIN U24230MH1993PTC075565.
Andheri Pharmaceuticals has 2 current directors:
- Hufriz Basta - Director
- Pharaoh Percy Basta - Director
The latest financial statements of Andheri Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Andheri Pharmaceuticals is U24230MH1993PTC075565. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Andheri Pharmaceuticals was incorporated on 13 December 1993, making it 33+ years old. It is registered with the Registrar of Companies, Mumbai.
Hufriz Basta was appointed as Director on 13 Dec 1993. Pharaoh Percy Basta was appointed as Director on 13 Dec 1993.
The registered office of Andheri Pharmaceuticals is at Andheri Hon Pharmacy313 Vivina Apartments Andheri West, Mumbai, Maharashtra, India – 400058.
Andheri Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Andheri Pharmaceuticals is compliant as of 11 September 2026. The company is actively filing with the Registrar of Companies.
Andheri Pharmaceuticals can be reached at its registered office: Andheri Hon Pharmacy313 Vivina Apartments Andheri West, Mumbai, Maharashtra, India – 400058.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
